Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alison Dawn Laws, M.D.

Co-Author

This page shows the publications co-authored by Alison Laws and Olga Kantor.
Connection Strength

0.956
  1. Comparison of Breast Cancer Staging Systems After Neoadjuvant Chemotherapy. Ann Surg Oncol. 2021 Nov; 28(12):7347-7355.
    View in: PubMed
    Score: 0.234
  2. Axillary Management After Neoadjuvant Endocrine Therapy for Hormone Receptor-Positive Breast Cancer. Ann Surg Oncol. 2021 Mar; 28(3):1358-1367.
    View in: PubMed
    Score: 0.223
  3. Node-Positive Patients Treated with Neoadjuvant Chemotherapy Can Be Spared Axillary Lymph Node Dissection with Wireless Non-Radioactive Localizers. Ann Surg Oncol. 2020 Nov; 27(12):4819-4827.
    View in: PubMed
    Score: 0.222
  4. Baseline Screening MRI Uptake and Findings in Women with =?20% Lifetime Risk of Breast Cancer. Ann Surg Oncol. 2020 Oct; 27(10):3595-3602.
    View in: PubMed
    Score: 0.221
  5. Oncotype DX testing in node-positive breast cancer strongly impacts chemotherapy use at a comprehensive cancer center. Breast Cancer Res Treat. 2021 Jan; 185(1):215-227.
    View in: PubMed
    Score: 0.056
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.